开云app官网登录入口网页版-官方正版

#JNC8#

13篇内容 | 816人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1972904, encodeId=40ed19e290437, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=JAMA cardiol：研究估算，执行美高血压新指南比JNC8多预防16万例总死亡，但增加了7.9万例急性肾损伤或衰竭事件, objectType=article, longId=139360, objectId=61f813936011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61f813936011, replyNumber=0, likeNumber=98, createdTime=2018-09-04, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61f813936011, moduleTitle=JAMA cardiol：研究估算，执行美高血压新指南比JNC8多预防16万例总死亡，但增加了7.9万例急性肾损伤或衰竭事件, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=61f813936011)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972903, encodeId=f5b319e2903b9, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=JNC8高血压指南或致部分人群高血压治疗不足, objectType=article, longId=54507, objectId=00505450e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00505450e5f, replyNumber=0, likeNumber=68, createdTime=2016-03-26, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00505450e5f, moduleTitle=JNC8高血压指南或致部分人群高血压治疗不足, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=00505450e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972902, encodeId=576a19e290287, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=J Chin Med Assoc：台湾高血压指南不同意JNC8的宽松策略, objectType=article, longId=45773, objectId=e34a45e7319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e34a45e7319, replyNumber=0, likeNumber=68, createdTime=2015-05-30, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e34a45e7319, moduleTitle=J Chin Med Assoc：台湾高血压指南不同意JNC8的宽松策略, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e34a45e7319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972901, encodeId=e3b619e290123, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=ACC 2014：JNC8高血压指南推荐的降压治疗更为宽松, objectType=article, longId=32636, objectId=bc4b32636cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc4b32636cf, replyNumber=0, likeNumber=53, createdTime=2015-01-12, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc4b32636cf, moduleTitle=ACC 2014：JNC8高血压指南推荐的降压治疗更为宽松, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bc4b32636cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972898, encodeId=760919e289876, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=刘力生：新指南（JNC8）值得我国借鉴, objectType=article, longId=28912, objectId=8d0d28912db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d0d28912db, replyNumber=0, likeNumber=65, createdTime=2014-08-26, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d0d28912db, moduleTitle=刘力生：新指南（JNC8）值得我国借鉴, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8d0d28912db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972900, encodeId=456e19e290053, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=施仲伟：美JNC8与我国高血压用药差异, objectType=article, longId=30041, objectId=f5c1300415b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5c1300415b, replyNumber=0, likeNumber=58, createdTime=2014-02-02, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5c1300415b, moduleTitle=施仲伟：美JNC8与我国高血压用药差异, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f5c1300415b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972894, encodeId=f14b19e2894b3, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=JAMA：JNC8版高血压指南可信度, objectType=article, longId=28478, objectId=f444284e83f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f444284e83f, replyNumber=0, likeNumber=60, createdTime=2014-01-09, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f444284e83f, moduleTitle=JAMA：JNC8版高血压指南可信度, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f444284e83f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972899, encodeId=8c1c19e289978, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=看（JNC8）降压目标变动的来龙与去脉, objectType=article, longId=28913, objectId=5bd128913ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bd128913ce, replyNumber=0, likeNumber=66, createdTime=2014-12-02, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bd128913ce, moduleTitle=看（JNC8）降压目标变动的来龙与去脉, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5bd128913ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972895, encodeId=203e19e2895a2, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=JNC8后如何打出一副好牌：降压药市场洗牌在即, objectType=article, longId=28598, objectId=924c2859822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=924c2859822, replyNumber=0, likeNumber=51, createdTime=2014-12-11, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=924c2859822, moduleTitle=JNC8后如何打出一副好牌：降压药市场洗牌在即, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=924c2859822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972897, encodeId=0e8919e28972b, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, objectType=article, longId=28725, objectId=acd428e2528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acd428e2528, replyNumber=0, likeNumber=71, createdTime=2014-08-13, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acd428e2528, moduleTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=acd428e2528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972893, encodeId=778919e289300, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=郭艺芳：2014美国成人高血压指南（JNC8）修定要点, objectType=article, longId=28409, objectId=df922840940, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df922840940, replyNumber=0, likeNumber=70, createdTime=2014-10-25, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df922840940, moduleTitle=郭艺芳：2014美国成人高血压指南（JNC8）修定要点, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=df922840940)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972892, encodeId=029019e28923a, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=JAMA：JNC8委员会发布2014年成人高血压治疗新指南, objectType=article, longId=28331, objectId=3dab28331b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dab28331b9, replyNumber=0, likeNumber=82, createdTime=2014-10-14, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dab28331b9, moduleTitle=JAMA：JNC8委员会发布2014年成人高血压治疗新指南, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3dab28331b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1972896, encodeId=622119e28969c, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, objectTitle=ASH/ISH与JNC8高血压指南存在关键性差异, objectType=article, longId=28600, objectId=3de028600d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3de028600d3, replyNumber=0, likeNumber=58, createdTime=2014-06-21, rootId=0, userName=ms8435843352634314, userId=4b8c2500026, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3de028600d3, moduleTitle=ASH/ISH与JNC8高血压指南存在关键性差异, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3de028600d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

JNC8

2020-05-29

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

JAMA cardiol：研究估算，执行美高血压新指南比JNC8多预防16万例总死亡，但增加了7.9万例急性肾损伤或衰竭事件

2018-09-04

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

JNC8高血压指南或致部分人群高血压治疗不足

2016-03-26

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

J Chin Med Assoc：台湾高血压指南不同意JNC8的宽松策略

2015-05-30

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

ACC 2014：JNC8高血压指南推荐的降压治疗更为宽松

2015-01-12

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

刘力生：新指南（JNC8）值得我国借鉴

2014-08-26

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

施仲伟：美JNC8与我国高血压用药差异

2014-02-02

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

JAMA：JNC8版高血压指南可信度

2014-01-09

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

看（JNC8）降压目标变动的来龙与去脉

2014-12-02

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

JNC8后如何打出一副好牌：降压药市场洗牌在即

2014-12-11

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

黄峻：JNC8不能否认β受体阻滞剂的“中国特色”

2014-08-13

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

郭艺芳：2014美国成人高血压指南（JNC8）修定要点

2014-10-25

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

JAMA：JNC8委员会发布2014年成人高血压治疗新指南

2014-10-14

ms8435843352634314 (审核中...)

前往app查看评论内容

#JNC8#

ASH/ISH与JNC8高血压指南存在关键性差异

2014-06-21

科室
- - 订阅+
  - 更多科室
工具
服务